PBD Biotech is a clinical-stage diagnostic company and pioneer in phage-based diagnostics.
PBD Biotech has raised $2.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2022.
PBD Biotech's investors include Foresight Group, Mercia Fund Managers, University of Nottingham, Midlands Engine Investment Fund, Anglia Capital Group.
PBD Biotech is headquartered in Birmingham, United Kingdom.
PBD Biotech is a clinical-stage diagnostic company and pioneer in phage-based diagnostics.
PBD Biotech is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PBD Biotech — Funding & Investors." VCBacked, October 17, 2022, https://www.vcbacked.co/company/pbd-biotech. Accessed November 11, 2026.
VCBacked. (2022). PBD Biotech — Funding & Investors. Retrieved November 11, 2026, from https://www.vcbacked.co/company/pbd-biotech
{{cite web |title=PBD Biotech — Funding & Investors |url=https://www.vcbacked.co/company/pbd-biotech |website=VCBacked |access-date=November 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at PBD Biotech? Request a listing update